Find a Provider

Frederick-Christian-Eilber Photo

Is Super

Specialty:: Surgery, Complex General Surgical Oncology
Surgery
Department Affiliation:: Surgery
Hospital Affiliation:: Ronald Reagan UCLA Medical Center
State License:: A62408
Languages:: Spanish
Phone:: 310-825-7086
Health Plans:: Accepted Plans

About Me

Preferred Name: Fritz C. Eilber

Frederick (Fritz) C. Eilber is a Professor of Surgery, Division of Surgical Oncology and Chief of the Cancer Surgery Service at UCLA, with a dual appointment in the Department of Molecular and Medical Pharmacology. He is Director of the UCLA Sarcoma Clinical / Translational Research Program within the Jonsson Comprehensive Cancer Center and the Sarcoma Program Area within the Institute of Molecular Medicine.

Business Office
10833 Le Conte Ave
Room 54-140 CHS
Los Angeles, CA 90095

Patient Stories

Caring, Competence and Teamwork produced Good Results

Links

uclahealth.org/sarcoma
surgery.ucla.edu/division-thoracic-surgery
surgery.ucla.edu
surgery.ucla.edu/division-surgical-oncology
uclahealth.org/community-cancercare
uclahealth.org/community-cancercare/westwood

Primary Office: Surgical Oncology Center
Primary Address: 200 UCLA Medical Plaza
Suite B265 (B2 Level)
Los Angeles, California 90095
: Get Directions
: View Map
Phone: 310-825-7086

Fellowship: Surgical Oncology, Memorial Sloan-Kettering Cancer Center, 2002-2004
Residency: General Surgery, UCLA School of Medicine, 1996-2002
Internship: General Surgery, UCLA School of Medicine, 1995-1996
Degree: UCLA School of Medicine, MD, 1995

Interests

Melanoma
Sarcoma
Soft Tissue Tumors
Solid Tumors

Research Interests: "My research is focused on translating molecular oncology from the laboratory to the clinic in a rapid and clinically relevant manner with the goal of swiftly impacting patient care. Our long-term objective is to rationally apply molecularly targeted therapies in the context of defined genetic lesions thus developing effective and individualized therapeutic strategies for patients with sarcoma and other solid tumors. We have recently focused on applying molecular imaging to evaluate response to systemic therapy (traditional chemotherapy, targeted therapy) and direct regional therapies (surgery, radiation therapy, embolization) in solid tumors."
Publications: Link to my PubMed publications >

In The News

Loss of Tumor Suppressor Gene Essential to Transforming Benign Nerve Tumors into Cancers
Imaging: FDG-PET/CT: early predictor of treatment response in soft-tissue sarcoma
Study finds PET superior to standard tools for evaluating cancer treatment
PET study garners widespread media attention
Using PET/CT Imaging, Researchers Can Tell in a Single Treatment if Chemotherapy is Working
Father and son: Fighting sarcoma with different tools

Awards

2008 Shelby Richter Research Award - Sarcoma Foundation America
2008 Society of Nuclear Medicine Siemens Award (Senior Author)
2008 Society of Nuclear Medicine Travel Award (Senior Author)
2008 ASCO Foundation Merit Award (Abst ID:10510, Senior Author)
2008 ASCO Foundation Merit Award (Abst ID:10528, Senior Author)
2007 Jonsson Cancer Center Award for Clinical Excellence, UCLA
2007 ASCO Foundation Merit Award (Senior Author)
2004 Chairman's Clinical Research Award, MSKCC Dept of Surgery
2004 ASCO Foundation Merit Award
2002 Outstanding Student Teaching Award, UCLA Dept of Surgery
1996 Outstanding 1st Year Resident, UCLA Dept of Surgery

Webinar URL: Medical Education
Leiomyosarcoma: Personalized Sarcoma Therapy

Frederick C. Eilber, MD click here to update your profile

Back to search

Find a Provider

Find a Provider

Share this

Patient Stories

Medical Education